Regenerative Therapy With Autologous Stromal Vascular Fraction Derived Mesenchymal Stem Cells and Platelet-rich Plasma to Treat Complex Perianal Diseases
- Conditions
- Anal FissurePerianal Crohn DiseasePerianal FistulaRectovaginal FistulaPerianal Fistula Due to Crohn's Disease
- Registration Number
- NCT05709717
- Lead Sponsor
- Kantonsspital Winterthur KSW
- Brief Summary
Consecutive patients with complex anal fistula were prospectively followed for 12 months. Routine MRI was performed before and at 4 and 12 months after surgery. Continence was assessed likewise using a validated questionnaire. Fistula were drained with setons prior surgery. SVF was harvested from subcutaneous abdominal fat and PRP from peripheral blood. Distal fistulectomy to the sphincter was performed and the wound left open, while the internal orifice was closed. SVF-PRP was injected around the fistula. Patients showered their excision wound until dry. Outcomes were reported as median \& interquartile range (IQR)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NOT_YET_RECRUITING
- Sex
- All
- Target Recruitment
- 50
Perianal fistula Perianal fissure Anovaginal fistula Rectovaginal fistula Perianal Crohn's disease
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical Healing 1 year Absence of fistula opening and discharge, well-being
MRI healing 1year Absence of active fistula and abscess
- Secondary Outcome Measures
Name Time Method Fecal continence 1 year Vaizey score
Quality of life (general and related to perianal diseases) 1 year FIQoL
Costs 1 year Direct cost to patient, institution, and payee
Trial Locations
- Locations (1)
Kantonsspital Winterthur
🇨ðŸ‡Winterthur, Switzerland